» Articles » PMID: 36625090

The Cynosure of CtBP: Evolution of a Bilaterian Transcriptional Corepressor

Overview
Journal Mol Biol Evol
Specialty Biology
Date 2023 Jan 10
PMID 36625090
Authors
Affiliations
Soon will be listed here.
Abstract

Evolution of sequence-specific transcription factors clearly drives lineage-specific innovations, but less is known about how changes in the central transcriptional machinery may contribute to evolutionary transformations. In particular, transcriptional regulators are rich in intrinsically disordered regions that appear to be magnets for evolutionary innovation. The C-terminal Binding Protein (CtBP) is a transcriptional corepressor derived from an ancestral lineage of alpha hydroxyacid dehydrogenases; it is found in mammals and invertebrates, and features a core NAD-binding domain as well as an unstructured C-terminus (CTD) of unknown function. CtBP can act on promoters and enhancers to repress transcription through chromatin-linked mechanisms. Our comparative phylogenetic study shows that CtBP is a bilaterian innovation whose CTD of about 100 residues is present in almost all orthologs. CtBP CTDs contain conserved blocks of residues and retain a predicted disordered property, despite having variations in the primary sequence. Interestingly, the structure of the C-terminus has undergone radical transformation independently in certain lineages including flatworms and nematodes. Also contributing to CTD diversity is the production of myriad alternative RNA splicing products, including the production of "short" tailless forms of CtBP in Drosophila. Additional diversity stems from multiple gene duplications in vertebrates, where up to five CtBP orthologs have been observed. Vertebrate lineages show fewer major modifications in the unstructured CTD, possibly because gene regulatory constraints of the vertebrate body plan place specific constraints on this domain. Our study highlights the rich regulatory potential of this previously unstudied domain of a central transcriptional regulator.

Citing Articles

Clinical significance of peripheral blood DDR1 and CtBP gene methylation detection in patients with acute pancreatitis.

Ma Z, Ma X, Zhu H, Cheng L, Gou L, Zhang D Epigenetics. 2024; 19(1):2421631.

PMID: 39485950 PMC: 11540100. DOI: 10.1080/15592294.2024.2421631.


A regulatory role for the unstructured C-terminal domain of the CtBP transcriptional corepressor.

Raicu A, Suresh M, Arnosti D J Biol Chem. 2023; 300(1):105490.

PMID: 38000659 PMC: 10788531. DOI: 10.1016/j.jbc.2023.105490.


A regulatory role for the unstructured C-terminal domain of the CtBP transcriptional corepressor.

Raicu A, Suresh M, Arnosti D bioRxiv. 2023; .

PMID: 37292674 PMC: 10245716. DOI: 10.1101/2023.05.19.541472.


Off the deep end: What can deep learning do for the gene expression field?.

Raicu A, Fay J, Rohner N, Zeitlinger J, Arnosti D J Biol Chem. 2022; 299(1):102760.

PMID: 36462664 PMC: 9801099. DOI: 10.1016/j.jbc.2022.102760.

References
1.
Kim G, Shoda K, Tsuge T, Cho K, Uchimiya H, Yokoyama R . The ANGUSTIFOLIA gene of Arabidopsis, a plant CtBP gene, regulates leaf-cell expansion, the arrangement of cortical microtubules in leaf cells and expression of a gene involved in cell-wall formation. EMBO J. 2002; 21(6):1267-79. PMC: 125914. DOI: 10.1093/emboj/21.6.1267. View

2.
Poortinga G, Watanabe M, Parkhurst S . Drosophila CtBP: a Hairy-interacting protein required for embryonic segmentation and hairy-mediated transcriptional repression. EMBO J. 1998; 17(7):2067-78. PMC: 1170551. DOI: 10.1093/emboj/17.7.2067. View

3.
Musselman C, Kutateladze T . Characterization of functional disordered regions within chromatin-associated proteins. iScience. 2021; 24(2):102070. PMC: 7873657. DOI: 10.1016/j.isci.2021.102070. View

4.
Barroilhet L, Yang J, Hasselblatt K, Paranal R, Ng S, Rauh-Hain J . C-terminal binding protein-2 regulates response of epithelial ovarian cancer cells to histone deacetylase inhibitors. Oncogene. 2012; 32(33):3896-903. DOI: 10.1038/onc.2012.380. View

5.
Dcona M, Morris B, Ellis K, Grossman S . CtBP- an emerging oncogene and novel small molecule drug target: Advances in the understanding of its oncogenic action and identification of therapeutic inhibitors. Cancer Biol Ther. 2017; 18(6):379-391. PMC: 5536941. DOI: 10.1080/15384047.2017.1323586. View